Medical Specialty >> Pharmacy

Doctors Lounge - Pharmacy Answers

Back to Pharmacy Answers List

If you think you may have a medical emergency, call your doctor or 911 immediately. Doctors Lounge (www.doctorslounge.com) does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site.

DISCLAIMER: The information provided on www.doctorslounge.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Please read our 'Terms and Conditions of Use' carefully before using this site.

Date of last update: 9/5/2017.

Forum Name: Pharmacy & Drug Topics

Question: drug abuse


 Ravi_kant_verma - Mon Jul 23, 2007 4:15 am

my wife of 28 yrs old, is 4 months pegnant, she has taken alprax(aprazolam) 0.5 mg X 10 tabs in the night, she is ok now , but I want to know what will the effect on fetus?
 Dr. Chan Lowe - Mon Jul 23, 2007 5:29 pm

User avatar Hi Ravi_kant_verma,

Unfortunately, this is a difficult question to answer. Alprazolam is classified as pregnancy class D by the FDA. This category is where there is positive evidence of fetal risk but in some cases the benefit may outweigh the risk. If it were clearly a teratogen (birth defect causer) it would be classified as category X.

Probably the baby will be fine since it was a one time exposure and the baby is currently in a phase of growth where the body is mostly growing and not forming new parts.

I would recommend that you let your obstetrician know about the exposure and discuss this with her.

Best wishes.

| Check a doctor's response to similar questions

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us